Clinical
Pharmacology
a matter of enthusiasm!
Membership
Become a member of AGAH!
You can contribute your competence to the professional scientific organisation of medicinal product research.Events
Current Events of the AGAH
Read actual news about current activities of the AGAH. Participation pays off!
About us
What is the AGAH?
The Association for Applied Human Pharmacology (AGAH) focuses on exploratory medicinal product development and human pharmacological research
AGAH - Get to know us!
The Association for Applied Human Pharmacology (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. - AGAH) as a specialist medical-academic organisation focuses on exploratory medicinal product development and human pharmacological research.
AGAH sees itself as an organisation for everyone dealing with clinical pharmacological test programs, studies in the target population in early-stage medicinal product development and translational topics.
Details
Working groups of AGAH
Focus of our work
Our work focuses on the conception and planning of clinical pharmacological trials, their approval and testing processes, as well as their practical implementation and evaluation. Apart from the traditional areas of pharmacokinetics and pharmacodynamics, it covers the inclusion of biomarkers in clinical trials and the consideration of statistical and pharmacometric methods in the planning and evaluation of trials.
Researchers and developers from universities, (bio)pharmaceutical industry, contract research organisations, authorities and ethics committees come together in the AGAH. The interfaces to the preclinical stage and the later phases of clinical trials are not excluded but consciously and actively integrated into our academic work.
Responsible for the people
We are conscious of our special responsibility, which comes with the implementation of research projects in humans, especially when the trial participants do not gain any personal benefit of participating in the trials – a particular type of ethical challenge, especially in the early phases of clinical trials.
High-quality research projects with particular attention paid to safety aspects are therefore most important for the people participating as test subjects in these trials, but also for the knowledge gained for subsequent application in treatment. As an academic organisation we strive to make a contribution here.
International context
We started our work as a national organisation over 25 years ago and have moved with the times – today research is international, cross-border and varied; for example, the AGAH is a founding member of EUFEMED (European Federation of Exploratory Medicines Development), a consortium of specialist organisations with the same orientation for discussing and promoting early-stage medicinal product development at a European level.
Progress through exchange, dialogue and cooperation - this is how AGAH sees itself today and in the future.
Partner organisations
Current events
-
10. February 2021 @ 17:30 - 19:30
Covid vaccination – Q&A sessions for AGAH Members: Who would like to know more about it?
Webinar, -
1. March 2021 - 3. March 2021
6. German Pharm-Tox Summit 2021 – AGAH-Symposium: Clinical and economic aspects of medical application of biologics
, -
1. September 2021 - 17. December 2021
AGAH – Applied Course in Pharmacokinetics (2 days) September or December 2021
, -
1. October 2021 - 30. November 2021
Introductory Course in Exploratory Medicines Development – Part I and II / October and November 2021
, -
1. December 2021 - 31. January 2022
AGAH-Workshop “Applied Course Biostatistics”, December 2021 or January 2022
,
Note of condolence
Dear colleagues and friends
It is with a very heavy heart that the AGAH needs to share the passing of Prof. Dr. Hartmut Derendorf on November 23 2020, at the age of 67. He was a distinguished, world-renowned expert in pharmacokinetics and pharmacometrics and an engaged supporter of the AGAH during the past decades.
Hartmut Derendorf received his license as a pharmacist and PhD from the Univ. of Münster and did his postdoctoral fellowship subsequently at the Univ. of Florida, Gainesville. He joined the UF College of Pharmacy as a faculty member for more than 30 years including 25 years as chair of the department of pharmaceutics.
During his career, he impacted over 100 graduate students and postdoctoral fellows as well as more than 400 international exchange students and visiting scientists throughout his tenure. Dr. Derendorf published more than 500 publications and earned multiple international awards. His research interests included the pharmacokinetics and pharmacodynamics of corticosteroids, antibiotics and analgesics, as well as drug interactions and he was a pioneer in implementing the use of microdialysis to determine drug concentrations at the site of interest in tissues of patients.
He served both as regent and as president of the American College of Clinical Pharmacology (ACCP) and was thereby instrumental in setting up successful collaborations between AGAH and ACCP including several common annual meetings in Germany. As an inspiring speaker he was invited to numerous scientific AGAH meetings and workshops including the PK/PD Expertentreffen and will always be remembered for his phantastic personality, his scientific enthusiasm and his great humor that he often included in his talks.
Hartmut Derendorf is survived by his wife, Dr. Kerry Estes, and sons Kevin and Karsten with their wifes, and his beloved granddaughter Miller - our thoughts are with them.
The AGAH wishes to express deep gratitude and honors his memory for his many contributions to the society and to the global field of clinical pharmacology!
Lieber Hartmut, we still had many plans together but now rest in peace!
Andreas Kovar, PhD, FCP
(President of AGAH)
source picture: https://florida.academia.edu/HartmutDerendorf